(PharmaNewsWire.Com, January 07, 2017 ) DelveInsight’s Report: Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Ophthalmology Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety DelveInsight Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.
Report facts
DelveInsight Gene Therapy Ophthalmology Report: “Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape” provides in depth insights into the Ophthalmology gene therapy. It has covered 30+ gene therapies covering 25+ Pharmaceutical companies. Studies are performed for approximately 30+ specific indications under Ophthalmology. The Companies are utilizing 15 different technology platforms which have its own uniqueness and robustness. The Report is also giving insights about the vectors usage in Gene therapy which is approximately 85% for viral vectors, 10% for RNAi therapeutics and 5% for Non Viral vectors. The Report is also giving early winners of the Ophthalmology gene therapy market using DelveInsight proprietary Matrix Model.
Global Gene Therapy Overview & Pipeline Insights Trends in gene therapy partnering deals Current Prominent Research Areas and Key Players Companies Targeting Prominent Therapeutic Areas Number of Gene Therapies in Clinical Trials Number of Gene Therapies by Vectors used Technology and their innovative Companies Early Market Winners for Gene Therapy
Scope
A snapshot of the global Gene therapy market scenario, market trends & drivers, manacles of gene therapy. A review of the marketed Gene therapy products and marketing status Coverage of global gene therapies under development across the globe covering territories Competitive landscape of investigational products for key players and key therapy areas. The Gene Therapy report covers the product description, stage of development, licensors & collaborators, Development partner and Technology information The Report also provides the pre-clinical and clinical outcomes of the gene therapies
Reason to Buy
Complete Market and Pipeline intelligence and complete understanding over therapeutics development for gene therapy Devise corrective measures for pipeline projects by understanding Therapy area specific gene therapies Developing strategic initiatives to support your gene therapy development activities. Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business. Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
